Teleflex Incorporated (TFX), a provider of medical technologies, Thursday announced that it has named Jason Weidman as its Chief Executive Officer and President, effective June 8.
He succeeds Stuart Randle, who has been serving as the interim Chief Executive and President of the company since January.
Weidman has over 25 years of industry experience and joins Teleflex from Medtronic plc, where he held a number of senior leadership roles for over nearly two decades and was most recently SVP and President, Coronary & Renal Denervation, and SVP and President, Aortic, Peripheral and Venous.
In pre-market activity, TFX shares were trading at $132.95, down 0.28% on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.